MedTrace Logo

Image-guided Lymphadanectomy in AMIGO

NCT03283423 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-01-09

No results posted yet for this study

Summary

To perform image-guided laparoscopic intra-abdominal lymph node biopsy with goal of minimizing surgical risk and improving accuracy of biopsy.

Conditions

  • Lymphadenopathy Retroperitoneal
  • Lymphoma

Interventions

DEVICE

Image-guided Lymphadanectomy in AMIGO

Image guided laparoscopic lymph node biopsy

Sponsors & Collaborators

  • Siemens Corporation, Corporate Technology

    collaborator INDUSTRY

  • KARL STORZ Endoscopy-America, Inc.

    collaborator INDUSTRY

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Ali Tavakkoli, MD · Brigham and Women's Hopistal

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-25
Primary Completion
2020-03-20
Completion
2020-03-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03283423 on ClinicalTrials.gov